摘要
恶性组织细胞增生症实为一组异质性淋巴增生性疾病。主要包括间变性大细胞淋巴瘤 (ALCL)和外周T细胞淋巴瘤 (PTCL)等。本文综述了恶性组织细胞增生症命名的起源、临床特点、病理形态学、瘤细胞属性。
出处
《诊断病理学杂志》
CSCD
2003年第2期116-118,共3页
Chinese Journal of Diagnostic Pathology
参考文献23
-
1李佩娟,刘予.恶性组织细胞增生症的临床病理特点和细胞来源探讨[J].中华病理学杂志,1991,20(4):250-253. 被引量：5
-
2杨怀涛,李甘地,杨秀英,刘开凤.恶性组织细胞增生症的免疫组化─20例尸解研究[J].诊断病理学杂志,1995,2(1):13-15. 被引量：6
-
3鲁昌立,刘卫平,郭嘉,李甘地,李俸媛.应用组织芯片技术探讨“恶性组织细胞增生症”肿瘤细胞属性及其与EB病毒感染的关系[J].中华病理学杂志,2002,31(6):497-501. 被引量：10
-
4李维华,纪小龙.恶性组织细胞增生症的理论与实践[J].临床与实验病理学杂志,1991,7(3):240-242. 被引量：2
-
5Wilson MS, Weiss LM, Garter KC et al .Malignant histiocytosis: a reassesment of cases previously reported in 1975 based on paraffin section immunophenotyping studies. Cancer, 1990, 66: 530.
-
6Gogusev J, Nezelof C. Malignant histiocytosis: histologic, cytochemical,chromosomal, and molecular data with a nosologic discussion. Hmlatol Oncol Clin North Am, 1998,12:445.
-
7Scott RB, Robb-Smith AHT. Histiocytic medullary reticulosis. Lancet,1939,2:194.
-
8Rappaport H.Tumors of the hematopoietic systems. In: Atlas of Tumor Pathology,fascicle 8, series 1. Washington DC: Armed Forces Institutes of Pathology,Section Ⅲ, 1966.49.
-
9Weiss LM, Trela MJ, Cleary ML et al . Frequent immunoglobulin and T-cell receptor gene rearrangements in "histiocytic neoplasms" .Am J Pathol,1985,121:369.
-
10Morgan R, Smith SD, Hecht Bk et al .Lack of involvement of the c-fms and N-myc genes by chromosomal transloeation t(2;5) (p23;q35) common to malignancies with features of so-called malignant histio cytosis.Blood, 1989,73:2155.
二级参考文献19
-
1李佩娟，儿科病理学，1990年
-
2Ji Yanyou，Cancer，1989年，64卷，1281页
-
3Quintanilla-Martinez L, Jaffe ES. Commentary: aggressive NK cell lymphomas: insights into the spectrum of NK cell derived malignancies. Histopathology. 2000,37:372-374.
-
4Gentile TC, Uner AH, Hutchison RE, et al. CD3+, CD56+ aggressive variant of large granular lymphocyte leukemia. Blood, 1994, 84 :2315-2321.
-
5Schleiffenbaum B, Rüegg R, Zimmermann D, et al. High grade malignant lymphoma with clinical characteristics and immunophenotype of natural killer cells. Am J Hematol, 1995,49:221-231.
-
6Marsha C, Kinney MD. The role of morphologic features, phenotype, genotype, and anatomic site in defining extranodal T cell or NK cell neoplasms. Am J Clin Pathol, 1999,111(Suppl 1):S104-118.
-
7Jaffe ES, Harris NL, Stein H, et al. Pathology and genetics of tumors of heamatopoietic and lymphoid tissues. Lyon: International Agency for Research on Cancer Press,2001.191-194.
-
8Macon WR, Williams ME, Greer JP, et al. Natural killer-like T-cell lymphomas: aggressive lymphomas of T-large granular lymphocytes. Blood, 1996,87:1474-1483.
-
9Ohshima K, Fujisali T, Nagafuchi S,et al. Malignant histiocytosis derived from a common histiocyte clone in a patient with chronic Epstein-Barr virus infection. Leuk Lymphoma. 1995,17:355-360.
-
10Su IJ, Hsu YH, Lin MT,et al. Epstein-Barr virus-containing T-cell lymphoma presents with hemophagocytic syndrome mimicking malignant histiocytosis. Cancer, 1993,72: 2019-2027.
共引文献16
-
1杨华,王连有,周小鸽,吕红波,田昊,李洪梅.组织芯片技术在淋巴瘤研究中的应用[J].中国实验诊断学,2004,8(6):688-689.
-
2朱德茂,杨颖.38例恶性组织细胞增生症的临床与实验室诊断[J].实用癌症杂志,1994,9(2):101-103. 被引量：5
-
3李甘地.淋巴造血组织病理学的十年回顾和展望[J].中华病理学杂志,2005,34(8):499-501.
-
4张小玲,刘跃梅,廖红群,王华彬.恶性组织细胞增生症误诊10例分析[J].中国误诊学杂志,2005,5(12):2308-2309.
-
5勇威本.组织细胞肿瘤的重新认识、分类与临床特征[J].癌症进展,2006,4(2):152-156.
-
6张新立,史景泉,朱英桂.恶性组织细胞增生症累及卵巢一例报告[J].第三军医大学学报,1996,18(5):463-464.
-
7张喜平,陆贝.组织微阵列技术在非恶性肿瘤疾病中的应用[J].中国中西医结合外科杂志,2007,13(3):308-310.
-
8段元冬,尹飞,戴建军,甘娜,张红媛.儿童尸检141例病理报告与临床分析[J].中华儿科杂志,2008,46(5):344-346. 被引量：1
-
9厉健.勒雪病型恶性组织细胞增生症1例尸检报告[J].浙江医学,1998,20(1):28-29.
-
10王秋菊,吴娜.小儿恶性组织细胞增生症16例临床分析[J].临床和实验医学杂志,2009,8(10):107-107.
同被引文献31
-
1邓蕙,余泽波,段明纲.78例伤寒、副伤寒临床分析[J].重庆医科大学学报,2005,30(1):143-145. 被引量：3
-
2杨怀涛,李甘地,杨秀英,刘开凤.恶性组织细胞增生症的免疫组化─20例尸解研究[J].诊断病理学杂志,1995,2(1):13-15. 被引量：6
-
3[1]Jaffe ES,Harris NL,Stein H,et al.Pathology and genetics of tumors of haematopoietic and lymphoid tissues.Lyon:IARC Press,2001,275
-
4[3]Wilson MS,Weiss LM,Gater KC,et al.Malignant histiocytosis:A resessment of cases previously reported in 1975 based on paraffin section immunophenotyping studies.Cancer,1990,66:530
-
5[6]Mongkonsritragoon W,Li Cy,Phliky RL.True malignant histiocytosis.Mayo Clin Proc,1998,73 (6):520
-
6[7]Pileri SA,Grogan TM,Harris NL,et al.Tumors of histiocytes and accessory dendritic cells:An immunohistiochemical approach to classification from the International Lymphoma Study Group based on 61 cases.Histopathol,2002,41:1
-
7[8]Favara BE,Feller AC,Paul M,et al.Contemporary classification of histiocytic disorders.The WHO Committee on Histiocytic/Reticulum Cell Proliferations Reclassication Working Group of the Histiocyte Society.Med Pediatr Oncol,1997,29 (3):157
-
8[9]Homick JL,Jaffe ES,Fletcher C.Etranodal histiocytic sarcoma:Clinicopathologic analysis of 14 cases of a rare ephitheliaoid malignancy.AM JsurgPathol,2004,28:1133
-
9[10]Vos JA,Abbondanzo SL,Barekman CL,at al.Histiocytic sarcoma:A study of five cases including the histiocyte marker CD163.Mod Pathol,2005,693
-
10[11]Jubran RF,Marachelian A,Dorey F,et al.Predictors of outcome in children with Langerhans cell histiocytosis.Pediatric Blood&Cancer,2005,45 (1):37
-
1王胜军,杨卫东,赵小虎,全志永,易婧薇,马晓伟,李桂玉,杨治平,汪静.^18F—FDG PET／CT诊断多发癌的价值[J].国际放射医学核医学杂志,2013,37(2):96-99. 被引量：2
-
2胡盛惠.细胞因子在淋巴增生性疾病治疗中的应用──自1991年以来的文献复习(二)[J].山西白血病,1994,3(4):246-249.
-
3罗杰,李挺,袁莉云,王泰龄,卞美璐,张敏,何秀云,张晶.人乳头状瘤病毒感染与宫颈癌前病变的关系[J].中华病理学杂志,1999,28(4):248-251. 被引量：20
-
4王建,张功亮,刘勇.胰腺血管平滑肌脂肪瘤1例并文献复习[J].临床与实验病理学杂志,2013,29(9):1015-1017. 被引量：2
-
5黄川英.白血病化疗时血及骨髓的细胞形态学改变探讨[J].大家健康（学术版）,2013(2):108-108. 被引量：1
-
6弓娟琴.CD30淋巴增生性疾病谱:淋巴瘤样丘疹病到间变性大细胞淋巴瘤[J].国外医学（皮肤性病学分册）,1998,24(2):105-108.
-
7管玲,杜润家,王丽云,袁宏,张丽,陆云.常规超声与超声造影诊断宫颈癌的对比分析[J].中华医学超声杂志（电子版）,2011,8(4):863-867. 被引量：14
-
8林丽莉,王国林,董孟杰,孙美龄,刘侃峰,赵欣,王华涛,赵葵.无形态学改变的肺内FDG高代谢结节PET／CT显像一例[J].中华核医学与分子影像杂志,2016,36(2):188-189.
-
9刘南植,尹朝礼.胃镜形态学酷似良性隆起性病变的早期胃癌18例分析[J].内科急危重症杂志,2000,6(1):20-21. 被引量：5
-
10彭昭华.恶性组织细胞增生症瘤细胞属性研究进展[J].国外医学（生理病理科学与临床分册）,1993,13(1):16-17.
